Jagielska, B., Czubek, A., TaƂasiewicz, K., Twarowski, A., Rutkowski, P., Krzakowski, M., Saetre, B., & Malecki, M. (2018). Assessment of efficacy of trastuzumab (Herceptin) comprising adjuvant therapy of HER2+ breast cancer patients determined based upon statistical analysis of overall survival (OS) and disease-free survival (PFS). Molecular And Cellular Therapies, 6(1). doi:10.26781/2052-8426-2018-02